Tran Capital Management’s Pfizer PFE Stock Holding History

Tran Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-218,742	Closed	-$6.7M	–	85
2015 Q4	$6.7M	Sell	218,742 -2,240	-1%	-$70.5K	0.18%	36
2015 Q3	$6.58M	Sell	220,982 -2,055	-0.9%	-$65.9K	0.16%	33
2015 Q2	$7.09M	Buy	223,037 +1,239	+0.6%	+$40.4K	0.17%	30
2015 Q1	$7.32M	Sell	221,798 -17,233	-7%	-$548K	0.16%	29
2014 Q4	$7.06M	Buy	239,031 +3,464	+1%	+$99.3K	0.14%	33
2014 Q3	$6.61M	Buy	235,567 +29,011	+14%	+$814K	0.12%	38
2014 Q2	$5.82M	Sell	206,556 -700	-0.3%	-$20K	0.1%	48
2014 Q1	$6.32M	Sell	207,256 -8,353	-4%	-$249K	0.11%	39
2013 Q4	$6.27M	Sell	215,609 -10,619	-5%	-$309K	0.11%	34
2013 Q3	$6.17M	Sell	226,228 -4,006	-2%	-$109K	0.12%	32
2013 Q2	$6.12M	Buy	+230,234	New	+$6.36M	0.13%	27

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Tran Capital Management's PFE Position: Q1 2016 in Review

Tran Capital Management sold out of Pfizer (PFE) in Q1 2016, closing a stake of 218,742 shares — an estimated $6.7M sold.

Tran Capital Management first reported a position in PFE in Q2 2013 and held it in 11 quarters. The position peaked at $7.32M in Q1 2015. 1,969 funds tracked by Wall St. Rank hold PFE as of Q1 2016.

Tran Capital Management reported no remaining Pfizer position as of Q1 2016 after selling out during the quarter.
Tran Capital Management sold 218,742 Pfizer shares in Q1 2016, an estimated $6.7M.
Tran Capital Management first reported a position in Pfizer in Q2 2013 and held it in 11 quarters.
Tran Capital Management's Pfizer position peaked at $7.32M in Q1 2015.
1,969 funds tracked by Wall St. Rank held Pfizer as of Q1 2016.

Based on Tran Capital Management's 13F filing for Q1 2016, filed 13 May 2016.